Treatment for Adolescents With Depression Study (TADS): Safety Results.
Objective: To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO). Method: Safety assessments included adverse events (AEs) collected by...
| Published in: | Journal of the American Academy of Child & Adolescent Psychiatry Vol. 45; no. 12; pp. 1440 - 1456 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Published: |
Elsevier Science
December 2006
|
| Subjects: | |
| Online Access: | View this record in EBSCOhost |